2025 ISV Webinar

About the Webinar

Topic: Development of Nirsevimab: A Monoclonal Antibody for the Prevention of RSV Disease in Infants

Speaker: Tonya Villafana, AstraZeneca

Click here to join

Participation is free and no prerequisites are required.

All previous recordings can be accessed at the ISV YouTube Channel.